Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.60 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.60 |
| ▸ | CTSD | P07339 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.55 |
| ▸ | TFPI | P10646 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31123352 | 0.91 | TFPI (0.59) | BACE1BACE2CTSDOPRD1TFPI | |
| SCHEMBL30883259 | 0.88 | TFPI (0.62) | BACE1BACE2TFPI | |
| SCHEMBL30184264 | 0.87 | TFPI (0.62) | BACE1BACE2CTSDTFPI | |
| SCHEMBL29649718 | 0.86 | OPRD1 (0.60) | BACE1BACE2CTSDOPRD1 | |
| SCHEMBL30445403 | 0.86 | OPRD1 (0.50) | BACE1BACE2OPRD1 | |
| SCHEMBL30607373 | 0.86 | BACE1 (0.62) | BACE1BACE2CTSDOPRD1 | |
| SCHEMBL30512508 | 0.85 | OPRD1 (0.53) | BACE1BACE2CTSDOPRD1 | |
| SCHEMBL30906431 | 0.85 | BACE1 (0.63) | BACE1BACE2OPRD1TFPI | |
| SCHEMBL30430635 | 0.85 | BACE1 (0.64) | BACE1BACE2CTSD | |
| SCHEMBL30445796 | 0.84 | BACE1 (0.54) | BACE1BACE2OPRD1TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4436981-A1 | SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS | Ironwood Pharmaceuticals, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| WO-2023097210-A1 | SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2023-06-01 | — | — | WO | disclosed |